SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-088951
Filing Date
2019-03-28
Accepted
2019-03-27 21:51:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d730633d424b5.htm 424B5 399878
2 GRAPHIC g730633g07v79.jpg GRAPHIC 41492
3 GRAPHIC g730633g10b61.jpg GRAPHIC 23917
4 GRAPHIC g730633g19p38.jpg GRAPHIC 131345
5 GRAPHIC g730633g98e51.jpg GRAPHIC 96192
  Complete submission text file 0001193125-19-088951.txt   804871
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217172 | Film No.: 19709755
SIC: 2834 Pharmaceutical Preparations